Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marian Mitroiu"'
Autor:
Xiaomei Leng, Piotr Leszczyński, Slawomir Jeka, Shengyun Liu, Huaxiang Liu, Malgorzata Miakisz, Jieruo Gu, Lali Kilasonia, Mykola Stanislavchuk, Xiaolei Yang, Yinbo Zhou, Qingfeng Dong, Marian Mitroiu, Janet Addison, Mourad F. Rezk, Xiaofeng Zeng
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-9 (2024)
Abstract Background Equivalent efficacy and comparable pharmacokinetic, immunogenicity, and safety profiles of the biosimilar BAT1806/BIIB800 and reference tocilizumab (TCZ) in participants with moderate-to-severe rheumatoid arthritis (RA) have been
Externí odkaz:
https://doaj.org/article/7321449214ab450ba0c7e50ae94dea07
Autor:
Gabrielle Simoneau, Marian Mitroiu, Thomas PA Debray, Wei Wei, Stan RW Wijn, Joana Caldas Magalhaes, Justin Bohn, Changyu Shen, Fabio Pellegrini, Carl de Moor
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 2 (2024)
Aim: Comparative effectiveness research using real-world data often involves pairwise propensity score matching to adjust for confounding bias. We show that corresponding treatment effect estimates may have limited external validity, and propose tw
Externí odkaz:
https://doaj.org/article/ab90d666593b46258e60422b08a83b78
Autor:
Marian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, Aranzazu Sancho, Roser Vives, Stella Pesiou, Juan Manuel Fontanet, Ferran Torres, Stavros Nikolakopoulos, Konstantinos Pateras, Gerd Rosenkranz, Martin Posch, Susanne Urach, Robin Ristl, Armin Koch, Spineli Loukia, Johanna H. van der Lee, Kit C. B. Roes
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-16 (2018)
Abstract Background The ASTERIX project developed a number of novel methods suited to study small populations. The objective of this exercise was to evaluate the applicability and added value of novel methods to improve drug development in small popu
Externí odkaz:
https://doaj.org/article/62ce11d1d252459895811aa84238b1e0
Publikováno v:
Pharmaceutical Statistics, 21, 5, pp. 1037-1057
Pharmaceutical Statistics, 21, 1037-1057
Pharmaceutical Statistics, 21, 1037-1057
Contains fulltext : 283289.pdf (Publisher’s version ) (Open Access) Estimands aim to incorporate intercurrent events in design, data collection and estimation of treatment effects in clinical trials. Our aim was to understand what estimands may cor
Autor:
Mark P. Arts, Roel F. M. R. Kersten, Marian Mitroiu, A. de Gast, S.M. van Gaalen, F. C. Oner, Kit C.B. Roes
Publikováno v:
Global Spine Journal, 12, 8, pp. 1687-1695
Global Spine Journal, 12, 1687-1695
Global Spine Journal, 12, 1687-1695
Study Design: Randomized controlled trial. Objectives: Lumbar interbody fusion with cages is performed to provide vertebral stability, restore alignment, and maintain disc and foraminal height. Polyetheretherketone (PEEK) is commonly used. Silicon ni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d4d1f26a1cf438959442e874388df0
https://repository.ubn.ru.nl/handle/2066/287918
https://repository.ubn.ru.nl/handle/2066/287918
Autor:
Mark P. Arts, Steven M. van Gaalen, Arthur de Gast, Marian Mitroiu, F. Cumhur Oner, Kit C.B. Roes, Roel F. M. R. Kersten
Publikováno v:
J Spine Surg
Journal of Spine Surgery, 7, 249-251
Journal of Spine Surgery, 7, 2, pp. 249-251
Journal of Spine Surgery, 7, 249-251
Journal of Spine Surgery, 7, 2, pp. 249-251
BACKGROUND: During lumbar spinal fusion, spacer cages are implanted to provide vertebral stability, restore sagittal alignment, and maintain disc and foraminal height. Polyetheretherketone (PEEK) is commonly used by most spine surgeons. Silicon nitri
Publikováno v:
Journal of Clinical Epidemiology, 125, pp. 198-200
Journal of Clinical Epidemiology, 125, 198-200
Journal of Clinical Epidemiology, 125, 198-200
Contains fulltext : 225506.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b03835675ef0352c56f9d38f39cc4b
https://hdl.handle.net/2066/225506
https://hdl.handle.net/2066/225506
Publikováno v:
Trials, 21, 1
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Trials, 21
Trials
Trials, Vol 21, Iss 1, Pp 1-14 (2020)
Trials, 21
Trials
Background An estimand defines the target of estimation for a clinical trial through specification of the treatment, target population, variable, population-level summary and of the strategies for intercurrent events. A carefully defined estimand ali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f6f959ee9a506263ea218eaa9019a4
https://hdl.handle.net/2066/225029
https://hdl.handle.net/2066/225029
Autor:
Maarten van Smeden, Karel G.M. Moons, Timo B. Brakenhoff, Rolf H.H. Groenwold, Marian Mitroiu, Ruth H. Keogh
Publikováno v:
Journal of Clinical Epidemiology, 98, 89. Elsevier USA
Objectives In medical research, covariates (e.g., exposure and confounder variables) are often measured with error. While it is well accepted that this introduces bias and imprecision in exposure-outcome relations, it is unclear to what extent such i
Autor:
Robin Ristl, Caridad Pontes, Stavros Nikolakopoulos, Aranzazu Sancho, Konstantinos Pateras, Roser Vives, Juan Manuel Fontanet, Ferran Torres, Martin Posch, Katrien Oude Rengerink, Stella Pesiou, Kit C.B. Roes, Marian Mitroiu, Spineli Loukia, Johanna H. van der Lee, Gerd K. Rosenkranz, Armin Koch, Susanne Urach
Publikováno v:
Orphanet journal of rare diseases, 13(1). BioMed Central
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-16 (2018)
Orphanet Journal of Rare Diseases, 13(1), 200. BioMed Central
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-16 (2018)
Orphanet Journal of Rare Diseases, 13(1), 200. BioMed Central
Background The ASTERIX project developed a number of novel methods suited to study small populations. The objective of this exercise was to evaluate the applicability and added value of novel methods to improve drug development in small populations,